Erratum to "Evaluation of novel tropane analogues in comparison with the binding characteristics of [18F]FP-CIT and [131I]β-CIT" [Nucl. Med. Biol. 2007;34:211-219] (DOI:10.1016/j.nucmedbio.2006.12.001);A simplified method for the measurement of nonmetabolized 2-[18F]F-A-85380 in blood plasma using solid-phase extraction

Nuclear Medicine and Biology

Volumn 34, Issue 2, 2007, Pages 221-228

  Shumway, Dean A ^a   Pavlova, Olga A ^a   Mukhin, Alexey G ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

2 18F F A 85380; Nicotinic acetylcholine receptors; Plasma; Positron emission tomography; Solid phase extraction

Indexed keywords

2 FLUORO 3 (2 AZETIDINYLMETHOXY)PYRIDINE F 18; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

EID: 33846986308     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.04.009     Document Type: Erratum

References (22)

1. 18F-fluoro-A-85380 in healthy volunteers. J Nucl Med 44 (2003) 596-601
2. 18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J 17 (2003) 1331-1333
3. 18F-fluoro-A-85380 and PET. J Nucl Med 46 (2005) 240-247
4. 18F]F-A-85380 and PET. Nucl Med Biol 32 (2005) 585-591
5. Lukas R.J., Changeux J.P., Le Novere N., Albuquerque E.X., Balfour D.J.K., and Berg D.K. International union of pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51 (1999) 397-401
6. Holladay M.W., Dart M.J., and Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J Med Chem 40 (1997) 4169-4194
7. Maskos U., Molles B.E., Pons S., Besson M., Guiard B.P., and Guilloux J.P. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 (2005) 103-107
8. Tapper A.R., McKinney S.L., Nashmi R., Schwarz J., Deshpande P., and Labarca C. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 (2004) 1029-1032
9. Gotti C., Riganti L., Vailati S., and Clementi F. Brain neuronal nicotinic receptors as new targets for drug discovery. Curr Pharm Des 12 (2006) 407-428
10. Herzog H., Minnerop M., Eschner W., Jessen F., Schutz C., and Schmaljohann J. Distribution volume of the nicotinic acetylcholine receptor ligand 2-[F-18]F-A-85380: nonsmokers versus smokers. Neuroimage 31 (2006) T156
11. Kendziorra K., Meyer P., Wolf H., Barthel H., Hesse S., and Seese A. Cerebral nicotinic acetylcholine receptors in patients with Alzheimer's disease assessed with 2-[18F]F-A85380 PET-correlations to dementia severity. Neuroimage 31 (2006) T39
12. Kimes A.S., Chefer S., Contoreggi C.S., Hall A., Horti A., and Vaupel D.B. In vivo quantification of the greater densities of alpha4beta2* nicotinic acetylcholine receptors in smokers compared to non-smokers. Neuroimage 31 (2006) T153
13. Meyer P., Kendziorra K., Hesse S., Becker G., Strecker K., and Hensel A. Nicotinic acetylcholine receptors (alpha4beta2) and their relationship to cognitive and mood symptoms in Parkinson disease: A 2-[18F]-F-A-85380 PET study. Neuroimage 31 (2006) T151
14. Meyer P., Hesse S., Kendziorra K., Becker G., Wegner F., and Schildan A. Dissociation between striatal alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2) and dopamine transporters (DAT) in Parkinson disease: A 2-[18F]-F-A-85380 PET/[123I]-FP-CIT SPECT study. Neuroimage 31 (2006) T157
15. Brody A.L., Mandelkern M.A., London E.D., Olmstead R.E., Farahi J., and Scheibal D. Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63 (2006) 907-915
16. Picard F., Bruel D., Servent D., Saba W., Fruchart-Gaillard C., and Schollhorn-Peyronneau M.-A. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 129 (2006) 2047-2060
17. 18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48 (2003) 25-34
18. 18F]fluoro-A-85380. J Nucl Med 40 (1999) 1374-1380
19. 18F]F-A-85380. Neuroimage 31 (2006) T103
20. 18F]A-85380). J Labelled Compd Radiopharm 41 (1998) 309-318
21. 18F]A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol 25 (1998) 599-603
22. 123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates. Nucl Med Biol 28 (2001) 91-96